Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lentini

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 28, 2007
Does the evidence matter in medicine? The retinoblastoma paradigmDomenico Mastrangelo, Sonia De Francesco, Aldo Di Leonardo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 2, 2008
The retinoblastoma paradigm revisitedDomenico Mastrangelo, Sonia De Francesco, Aldo Di Leonardo, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Missing evidences in cancer genetics: the retinoblastoma paradigmDomenico Mastrangelo, Aldo Di Leonardo, Laura Lentini, et al.
European Journal of Medicinal Chemistry|July 13, 2016
Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screeningIvana Pibiri, Laura Lentini, Marco Tutone, et al.
International Journal of Molecular Sciences|July 10, 2020
Investigating REPAIRv2 as a Tool to Edit <i>CFTR</i> mRNA with Premature Stop CodonsRaffaella Melfi, Patrizia Cancemi, Roberta Chiavetta, et al.
Endocrine|March 16, 2020
Glucagon-like peptide-2 analog and inflammatory state in obese miceSara Baldassano, Antonella Amato, Simona Terzo, et al.
International Journal of Molecular Sciences|September 9, 2020
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model SystemsIvana Pibiri, Raffaella Melfi, Marco Tutone, et al.
International Journal of Pharmaceutics|April 10, 2020
Inhalable nano into micro dry powders for ivacaftor delivery: The role of mannitol and cysteamine as mucus-active agentsBarbara Porsio, Laura Lentini, Francesca Ungaro, et al.
International Journal of Molecular Sciences|July 10, 2019
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, et al.
Genetics in Medicine Open|January 6, 2026
CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)Riccardo Perriera, Anabela S Ramalho, Francois Vermeulen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 28, 2007
Does the evidence matter in medicine? The retinoblastoma paradigmDomenico Mastrangelo, Sonia De Francesco, Aldo Di Leonardo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 2, 2008
The retinoblastoma paradigm revisitedDomenico Mastrangelo, Sonia De Francesco, Aldo Di Leonardo, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Missing evidences in cancer genetics: the retinoblastoma paradigmDomenico Mastrangelo, Aldo Di Leonardo, Laura Lentini, et al.
European Journal of Medicinal Chemistry|July 13, 2016
Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screeningIvana Pibiri, Laura Lentini, Marco Tutone, et al.
International Journal of Molecular Sciences|July 10, 2020
Investigating REPAIRv2 as a Tool to Edit <i>CFTR</i> mRNA with Premature Stop CodonsRaffaella Melfi, Patrizia Cancemi, Roberta Chiavetta, et al.
Endocrine|March 16, 2020
Glucagon-like peptide-2 analog and inflammatory state in obese miceSara Baldassano, Antonella Amato, Simona Terzo, et al.
International Journal of Molecular Sciences|September 9, 2020
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model SystemsIvana Pibiri, Raffaella Melfi, Marco Tutone, et al.
International Journal of Pharmaceutics|April 10, 2020
Inhalable nano into micro dry powders for ivacaftor delivery: The role of mannitol and cysteamine as mucus-active agentsBarbara Porsio, Laura Lentini, Francesca Ungaro, et al.
International Journal of Molecular Sciences|July 10, 2019
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, et al.
Genetics in Medicine Open|January 6, 2026
CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)Riccardo Perriera, Anabela S Ramalho, Francois Vermeulen, et al.
Pageof 5